Recently, Segev et al. reported that in patients hospitalized for HF, the low ALT group had a higher incidence of cerebrovascular disease, dementia, and malignancy causing frailty and sarcopenia and a significantly higher all-cause mortality rate than those with high ALT [79]. The gene discussed is GPT; the disease is cerebrovascular disorder.